AstraZeneca在Q3业绩强劲后提出了2024年的预测,表明有可能实现年度财政目标。 AstraZeneca raises 2024 forecasts after strong Q3 performance, signaling potential to meet yearly financial goals.

一家大型制药公司Astra Zeneca在第三季度业绩超过预期后提高了2024年的收入和利润预测。 AstraZeneca, a major pharmaceutical company, has raised its 2024 revenue and profit forecasts following stronger-than-expected performance in the third quarter. 这一积极前景表明,该公司有望实现或超过该年度的财政目标。 This positive outlook suggests the company is on track to meet or exceed financial goals for the year.